Leading High-Quality Specialized Respiratory Disease Care
through the Integration of Biosensing and AI
through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Breath Gas Test System
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
MoreGlobal Presence
Who We Are
MISSION
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
PRODUCT FOCUS
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
VISION
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
News, Events and Highlights
UBreath at ERS 2026: Interactive FeNO Challenge and Precision Respiratory Diagnostics Draw Strong Interest
Barcelona, Spain — September 2026 — UBreath® successfully concluded an active and productive week at the European Respiratory Society (ERS) Congress 2026, held September 5–9 at Fira Gran Via in Barcelona. At Booth R0...
Impulse Oscillometry (IOS): The Sound Wave Revolution in Lung Testing
What Is Impulse Oscillometry? Imagine a lung function test that requires nothing more than sitting still and breathing normally. That is precisely what Impulse Oscillometry (IOS) offers—a quiet, non-invasive technology that uses sou...
The Importance of Repeatability in FeNO Testing: Why Consistency Matters
Fractional exhaled nitric oxide (FeNO) has become an indispensable tool in respiratory medicine. As a non-invasive biomarker of Type-2 airway inflammation, FeNO testing is now widely used in asthma diagnosis, monitoring, and treatment gui...
Advancing Precision in Respiratory Care
Please complete the form to contact our team